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Background: HFE, a major regulator of iron (Fe) homeostasis, has been suggested to be under positive selection in
both European and Asian populations. While the genetic variant under selection in Europeans (a non-synonymous
mutation, C282Y) has been relatively well-studied, the adaptive variant in Asians and its functional consequences
are still unknown. Identifying the adaptive HFE variants in Asians will not only elucidate the evolutionary history
and the genetic basis of population difference in Fe status, but also assist the future practice of genome-informed
dietary recommendation.
Results: Using data from the International HapMap Project, we confirmed the signatures of positive selection on
HFE in Asian populations and identified a candidate adaptive haplotype that is common in Asians (52.35–54.71 %)
but rare in Europeans (5.98 %) and Africans (4.35 %). The T allele at tag SNP rs9366637 (C/T) captured 95.8 % of this
Asian-common haplotype. A significantly reduced HFE expression was observed in individuals carrying T/T or C/T at
rs9366637 compared to C/C indicating a possible role of gene regulation in adaptation. We recruited 57 women of Asian
descent and measured Fe absorption using stable isotopes in those homozygous at rs9366637. We observed a 22 %
higher absorption in women homozygous for the Asian-common haplotype (T/T) compared to the control genotype
(C/C). Additionally, compared with a group of age-matched Caucasian women, Asian women exhibited significantly
elevated Fe absorption.
Conclusions: Our results indicate parallel adaptation of HFE gene in Europeans and Asians with different genetic
variants. Moreover, natural selection on HFE may have contributed to elevated Fe absorption in Asians. This study
regarding population differences in Fe homeostasis has significant medical impact as high Fe level has been linked to
an increased disease risk of metabolic syndromes.
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Adaptations to dietary intake during human evolution
have shaped the human genome and resulted in ethnic
variability in nutrient utilization and risk of diseases [1–3].
Classic examples have been established for the prevalence
of lactase persistence in Northern Europeans and East
Africans as an adaptation to milk consumption [4], high
copy number of AMY1 in populations ingesting starch-
rich diets [5], and the Asian alcohol flush reaction which
evolved as an adaptive response to alcohol consumption* Correspondence: koo4@cornell.edu; zg27@cornell.edu
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throughput genotyping and sequencing technology en-
ables genome-wide scans for signals of positive selection
and generates many hypotheses that await functional test-
ing and confirmation [7, 8]. Establishing these adaptive
variants is clinically relevant because the incompatibility
between genetic adaptations in the past and the modern
dietary environment could underlie many metabolic dis-
eases in the current society [1–3].
Iron (Fe) is an essential micronutrient involved in oxy-
gen transport, oxidative metabolism and immune function
[9, 10]. Iron deficiency (ID) is one of the most widespread
micronutrient deficiencies worldwide and may lead to ID
anemia, causing chronic fatigue, reduced work productivity,distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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and delayed physical and cognitive development in infants
[11–14]. On the other hand, Fe overload is also detri-
mental because of its participation in redox reaction, gen-
erating free radicals [15]. Fe overload is implicated in
a number of common chronic diseases, including type II
diabetes, cirrhosis, liver fibrosis, cardiomyopathy and
cancer [11, 16–22]. Maintaining Fe homeostasis is funda-
mentally critical for human health. Interestingly, there
is no mechanism for regulated excretion of Fe and Fe
homeostasis relies primarily on the tight regulation of
non-heme Fe absorption from the diet [15]. Dietary Fe
comes in two forms: heme Fe (animal-based products) and
non-heme Fe (animal- and plant-based products). Heme
Fe constitutes only about 10 % of total dietary Fe content
in a typical Western diet but accounts for about 2/3 of
absorbed iron because of its 4–8 times higher bio-
availability than non-heme Fe [15, 23, 24]. For individuals
(e.g. vegetarians) or populations consuming predomin-
antly plant-based diets and relying solely on the non-heme
form of Fe, they have a much higher risk for ID [24]. In
certain Asian populations (e.g. Chinese) with a long trad-
ition of consuming plant-based, iron-poor diets [24–26],
genetic variations enhancing non-heme Fe absorption
could have been especially beneficial and subject to posi-
tive natural selection. However, no such genetic variations
have been revealed to date. Furthermore, while population
differences in Fe status and the prevalence of ID have been
described [12, 27], the potential role of genetic variation
underlying these differences has remained largely unchar-
acterized. In the modern Fe-replete dietary environment,
identifying genetic variation enhancing Fe absorption is
especially important for future prevention of Fe overload
and its associated disorders.
HFE is one of the major regulators of non-heme Fe ab-
sorption and Fe homeostasis. The gene was the first found
to be implicated in hereditary hemochromatosis (HH), an
autosomal recessive disorder of Fe metabolism causing ex-
cess body Fe accumulation [28, 29]. A non-synonymous
mutation of HFE, C282Y (rs1800562), causes enhanced
non-heme Fe absorption, which could not be appropri-
ately down-regulated even in face of elevated Fe stores.
This mutation is responsible for more than 80 % of HH
found in Europe [28]. While this mutation has a frequency
of 5–14 % in northern European populations, it is nearly
absent outside of Europe [30, 31]. The relatively high fre-
quency of this mutation in European populations has been
suggested to be a result of recent positive selection, al-
though the underlying selection pressure has been contro-
versial [31–34]. While the hypothesis of dietary adaptation
to increase Fe absorption in heterozygous carriers of the
mutation has gathered lots of interest, it was shown that
C282Y-heterozygous individuals actually do not have ele-
vated dietary Fe absorption [35, 36]. The adaptive effect ofthis deleterious mutation might lie in the possibility that
C282Y homozygotes have Fe-deplete macrophages and
therefore gain resistance to macrophage-dwelling path-
ogens, which could not live without Fe [33, 34]. The se-
quence variation and haplotype structure at HFE are quite
different among continental populations, and interest-
ingly, Asian populations possess a high-frequency haplo-
type, referred to as the Asian-common haplotype, that is
rarely observed among European or African populations
[37]. This haplotype may have been driven to high fre-
quency by positive selection if it provided a selective
advantage. Consistently, a signal of positive selection on
HFE has been suggested in Chinese populations based on
patterns of single nucleotide polymorphism (SNP) allele
frequency around the HFE gene [38]. However, the possi-
bility of local adaptation of HFE in Asia requires further
confirmation and the underlying adaptive variants need to
be revealed.
We hypothesize that the Asian-common haplotype
present at a high frequency in Asian populations is associ-
ated with improved Fe stores and has a functional impact
on absorption of non-heme Fe. To test this hypothesis, we
performed multiple evolutionary analyses and unraveled a
regulatory variant in HFE with adaptive signals in Asian
populations. The impact of this regulatory variant on Fe
status and absorption was explored in a group of young
Asian women. With the Fe absorption data from this
study, we were able to further test for the first time if there
is population difference in Fe absorption between Asian
and Caucasian women.
Results
An Asian-common HFE haplotype has positive selection
signal and is associated with lower HFE expression
Haplotype analysis on HFE in 487 HapMap individuals
from three continents revealed 22 haplotypes (Fig. 1,
Additional file 1: Table S1). One haplotype was identified
with frequencies of 52.35–54.71 % in East Asian samples,
5.98 % in the North Europeans and 4.35 % in the West
Africans. This Asian-common haplotype could be tagged
by a single SNP, rs9366637 (ancestral allele C, derived
allele T). Among haplotypes carrying T at rs9366637 in
all samples, 95.80 % were the Asian-common haplotype
(Additional file 1: Table S1). Evolutionary analysis using
the iHS method revealed a signal of positive selection
on HFE only among the Asian samples but not in the
European or African samples (empirical p value = 0.011,
Additional file 1: Figure S1). Specifically, the tag SNP,
rs9366637, has an extreme iHS value of -2.89, suggesting
that its derived allele, T, is on an unusually long haplotype,
probably as a result of positive selection. Consistently, the
frequency of T is high in Asian populations but low in
Africans and Europeans (Additional file 1: Figure S2).
The population frequency divergence is also reflected
Fig. 1 The haplotype structure of HFE. SNPs within 20 Kb of HFE were used in this analysis. Data were retrieved from Hapmap 3. Each node
represents one haplotype and the size of each node is proportional to the frequency of the haplotype among all haplotypes observed. Each
node is also a pie chart and each sector represent the contribution of each population. The line between two nodes represents the evolutionary
connection between the two haplotypes and the mutations to convert the two haplotypes are indicated on the line. The red arrow points to the
Asia-prevalent haplotype, H19. The green node represents the haplotype (H1) observed in Chimpanzees
Fig. 2 Reduced HFE expression in carriers of T at SNP rs9366637.
Normalized expression level of HFE were measured in the lymphoblastoid
cell lines of 43 Chinese individuals from Beijing, China and 42 Japanese
individuals from Tokyo, Japan. Individuals with the C/C genotype had
significantly higher HFE expression when compared to those with the
C/T or T/T genotype (Student’s t test, p < 0.05)
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tween Asian and European populations, which is more ex-
treme than the 5 % genome-wide significance cutoff of
0.21 (empirical p value < 0.05). Between Asian and African
populations, the value is 0.28, slightly lower than the 5 %
significance cutoff of 0.34 [39]. The signals of population
differentiation of SNP rs9366637 were further confirmed
in another data set, the 1000 Genomes Project [40, 41].
The FST statistics for rs9366637 are 0.35 (empirical p
value = 0.017) between Asians and Europeans, 0.33 (em-
pirical p value = 0.039) between Asians and Africans, and
0.30 (empirical p value = 0.026) over the three continental
populations. The difference of derived allele frequency
(ΔDAF) between Asians and Europeans or Africans are
also among the top 5 % highest of genome-wide SNPs
(empirical p values are 0.016 and 0.024, respectively).
The presence of signals of positive selection suggest
the functional importance of the Asian-common haplo-
type. Consistent with our evolutionary analysis, previous
phenotypic association studies have shown that the T al-
lele of rs9366637 is associated with increased levels of cir-
culating ferritin in women [42, 43], and also with higher
birth weight in newborns [44].
The relationship between the genotype of rs9366637
and the HFE expression level was assessed using the
genotype and gene expression data of Asian individuals
in the Hapmap Project. Individuals carrying the geno-
type C/T or T/T had a significantly lower expression
level of HFE in lymphoblastoid cell lines (p = 0.02, 0.025,
respectively, Fig. 2), suggesting that the Asian-commonhaplotype may carry a regulatory variant(s) that down-
regulates the expression of HFE. The comparable expres-
sion level between C/T and T/T individuals also suggests
a dominant effect of the T allele. The lower HFE expres-
sion of C/T than C/C individuals was further confirmed in
four tissues, including lung, tibial nerve, EBV-transformed
lymphocytes and prostate (Additional file 1: Figure S3),
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(GTEx) [45]. No splicing effect was observed for rs9366637
on the relative expression of different HFE transcripts using
9 tissues from the GTEx Project. As a reduced expression
of HFE theoretically would lower the expression of hepcidin
and consequently lead to enhanced non-heme Fe absorp-
tion [9], we further investigated the impact of this Asian-
common haplotype on Fe absorption and Fe status.
Asian women carrying the Asian-common haplotype have
higher iron absorption
The effect of the Asian-common haplotype on non-heme
Fe absorption was assessed in a Fe absorption study involv-
ing a group of Asian women volunteers. Only women who
were homozygous at the tag SNP, rs9366637, were in-
cluded in the study so that the participants were either
homozygous carriers (with T/T genotype at the tag SNP)
or non-carriers (with C/C genotype) of the Asian-common
haplotype. Candidate participants were identified through
genotype screening on 57 healthy Asian women partici-
pants (Methods). In total, 10 non-carriers (8 Chinese, 1
Vietnamese, and 1 Korean) and 11 homozygous carriers
(9 Chinese and 2 Korean) of similar age consented to par-
ticipate in the Fe absorption study. These women partici-
pants did not have any health conditions that may cause
abnormal Fe status. Specifically, they had normal serum
concentrations of folate (>5 ng/mL), vitamin B-12 (>200
pg/mL) and C-reactive protein (CRP) (<10 mg/L), exclud-
ing possible influences on Fe status from vitamin defi-
ciency and inflammation [46]. Fe status markers, including
hemoglobin (Hb), serum ferritin (SF), serum transferrin re-
ceptor (sTfR) and hepcidin, were measured three times on
the genotype screening day (Additional file 1: Table S2),
on the dosing day when they consumed the Fe tracer
(Additional file 1: Table S3), and two weeks after the
dosing day (Table 1). All three datasets of Fe status revealedTable 1 Iron status indicators in Asian women participating in
the iron absorption study
Variable C/C (N = 10) T/T (N = 11)




















NOTE.—Data are expressed as the mean ± SD with the range in parentheses.
Iron status indicators were measured in blood obtained 2-weeks post-dosing.
Similar patterns were observed using data from the screening day and the
dosing day. * indicates p = 0.021 in one-tailed Wilcoxon rank sum test between
the two genotypessimilar patterns presented as follows. Firstly, consistent
with the fact that hepcidin is the master regulator of Fe
status [9], there were strong associations between hepcidin
and Hb (p = 0.018, R2 = 0.22, Fig. 3a), and SF (p = 4.24e-
08, R2 = 0.79, Fig. 3b). Secondly, compared between the
two genotypes, while the concentrations of Hb, SF and
hepcidin are similar, sTfR is significantly higher in homo-
zygous carriers than in non-carriers (p = 0.021, Table 1).
The percent Fe absorption in these 21 women was
highly variable (ranging from 5.1 to 60.6 %) and was in-
versely associated with SF (p = 0.004, R2 = 0.33, Fig. 4a)
and serum hepcidin (p = 0.009, R2 = 0.27, Fig. 4b). In
order to control for the well-known effect of Fe status
on intestinal Fe absorption efficiency, Fe absorption data
were normalized to a fixed serum ferritin concentra-
tion of 40 ug/L [47]. Mean normalized Fe absorption
data are presented in Fig. 5. After normalization, elevated
percent Fe absorption was evident in homozygous car-
riers, although the difference only approached significance
(p = 0.099). The absolute difference in percent Fe absorp-
tion between the two genotypes was 3.1 %, which reflected
an average increase of 22 % non-heme iron absorption in
female homozygous carriers of the Asian-common haplo-
type when compared with non-carriers in the face of simi-
lar Fe stores.
Asian women have higher iron absorption than Caucasian
women
To test if there are population differences in Fe status and
absorption between Asians and Caucasians, our data were
compared to data obtained from 18 healthy, similarly aged
Caucasian women recruited from the same university
campus using similar enrollment criteria and investi-
gated with the same experimental approaches [46]. Com-
parison of characteristics between the groups are presented
in Additional file 1: Table S4. No significant Fe status differ-
ences were found between the 21 Asian women participat-
ing in the Fe absorption study and the 18 age-matched
Caucasian women. However, percent Fe absorption normal-
ized to a fixed SF concentration (40 ug/L) was significantly
higher in Asian women independent of genotype when com-
pared to the Caucasian cohort (Fig. 5). Caucasian women
absorbed 12.02 ± 15.29 % of the supplemental non-heme Fe,
while Asian women with C/C genotype absorbed 16 % more
(p= 0.0078) and those with T/T genotype absorbed 42 %
more (p= 0.0018). Averaged over the two genotypes, Asian
women absorbed 30 % more non-heme Fe than Caucasians
(p= 0.00053). The independence of elevated non-heme Fe
absorption on HFE haplotype indicated that there might be
other absorption-enhancing genetic variants in Asians.
Discussion
This study utilized a multidisciplinary approach combining
evolutionary analyses and biomedical mass spectrometry
Fig. 3 Correlations between hepcidin and iron status markers. Iron status markers include a) hemoglobin and b) serum ferritin from 21 Asian
women participating in the Fe absorption study. Hepcidin and serum ferritin were transformed by natural logarithm. Black dashed lines represent
the linear regression line. The correlations between iron status markers and hepcidin were significant: hemoglobin (p = 0.018, R2 = 0.22), serum
ferritin (p = 4.24e-08, R2 = 0.79). Similar patterns were observed when using data from the screening day
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tional impact on non-heme Fe absorption in Asian popula-
tions. Evolutionary analyses identified an Asian-common
haplotype in the HFE gene that may have been under posi-
tive selection during evolution. Gene expression analyses
found significantly lower transcription of HFE among car-
riers of this haplotype. In support of a possible evolutionary
advantage, Asian subjects homozygous for this haplotype
exhibited higher non-heme Fe absorption after controlling
for Fe storage. Additionally, after controlling for Fe status,
Asian women exhibited significantly higher non-heme Fe
absorption when compared to age-matched Caucasian
women, supportive of a population differential genetic
basis for Fe homeostasis.
Our evolutionary analyses using genotype data from
multiple continental populations confirmed the presence
of an Asian-common HFE haplotype and positive selec-
tion signals on HFE in Asian populations [37, 38]. We
hypothesized that this frequency shift was due to the se-
lection pressure from the traditional plant-based diet inFig. 4 Correlations between iron absorption and iron status markers. Iron s
women participating in the Fe absorption study. Concentrations of serum
the stable iron isotope was administered. Hepcidin and serum ferritin were
the linear regression line. The correlations were all significant: serum ferritinAsia, which is known to be low in bioavailable Fe [25, 26].
Genetic mutations that enhance the ability to absorb non-
heme Fe from a plant-based diet may have increased the
ability to maintain adequate Fe status and thus incurred
positive natural selection. In support of this hypothesis,
the Asian-common-haplotype-tagging allele (T) of the tag
SNP rs9366637 is associated with increased levels of cir-
culating ferritin in women [42, 43], and also with higher
birth weight in newborns, as were the well-studied HFE
SNPs, C282Y and H63D [44]. An additional search in GRASP
(Genome-Wide Repository of Associations Between SNPs
and Phenotypes) [48] with SNPs in high linkage disequi-
librium (r2 > 0.8) with rs9366637 in Asian populations re-
vealed that one SNP rs7753826 is associated with mean
corpuscular hemoglobin concentration (MCHC), Hb, and
mean corpuscular volume (MCV) [49, 50], supporting the
involvement of rs9366637 and its linked SNPs in Fe
homeostasis regulation. Furthermore, individuals carrying
the Asian-common haplotype exhibited reduced HFE ex-
pression. A reduced expression of HFE theoretically wouldtatus markers included a) Serum ferritin and b) hepcidin from 21 Asian
ferritin and hepcidin were measured in blood obtained 2 weeks after
transformed by natural logarithm. The black dashed line represents
(p = 0.004, R2 = 0.33) and hepcidin (p = 0.009, R2 = 0.27)
Fig. 5 Normalized percent iron absorption in 21 Asian and 18
Caucasian women. Percent iron absorption was normalized to a
fixed serum ferritin concentration (40 ug/L). The Asian women were
split into two groups based on their genotype at SNP rs9366637.
Significantly higher percent iron absorption was evident in Asians of
both genotypes
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to enhanced Fe absorption [9]. Although the association
between the T allele and lower HFE expression was ob-
served consistently in the lymphoblastoid cell lines of
Asian individuals from the Hapmap Project (Fig. 2), and
also in four tissues from the GTEx Project (Additional
file 1: Figure S3), it is noteworthy that this association
is not significant in all tissues and cells included in the
GTEx project, including liver, where HFE mainly functions
[51]. It is likely that the small sample size of liver samples
(N = 31) in the GTEx project and their non-Asian ancestry
prevent the detection of the association. In the future, a
large number of liver samples from individuals of Asian ori-
gin will be ideal to further test this regulatory effect. Add-
itionally, future in-depth analysis on the signatures of
positive selection on HFE is needed. Although positive se-
lection signals on HFE have been consistently observed, the
underlying causal variant on the Asian-common haplo-
type is unclear. The observed associations may be due to a
beneficial coding or regulatory variant for HFE or even
nearby genes. It is noteworthy that HFE locates within a
cluster of histone genes, which also possess signals of
positive selection as detected with the iHS statistic [39].
The possibility could not be ruled out that the HFE Asian-
common haplotype has hitchhiked the positive selection
on nearby histone genes to reach high frequency.
To directly examine the impact of HFE haplotypes on
Fe absorption, a stable Fe isotope absorption study was
undertaken. Young women homozygous for the Asian-
common haplotype exhibited elevated non-heme Fe ab-
sorption when compared to women homozygous forother haplotypes after controlling for SF concentration.
However, the difference observed only approached sig-
nificance likely due to our limited sample size. Power
analysis based on our data suggested that a sample size
of 54 individuals per genotype would be required to de-
tect this difference as significant with 80 % power. While
the 3 % absolute difference in absorption may not appear
substantial, it is actually equivalent to a 14 ~ 20 ug/L de-
crease in SF concentration based on the relationship be-
tween SF and percent Fe absorption observed in this
and previous studies [52]. Considering that there are no
physiological regulatable routes of Fe excretion and excess
Fe accumulation continues across the lifespan [53], a 22 %
increase in percent Fe absorption might have significant
health implications if maintained across the lifecycle be-
cause high iron status has been linked to an increased risk
of metabolic diseases [18, 21, 22].
Fe status is one of the major determinants of non-heme
Fe absorption, with either SF or serum hepcidin explain-
ing approximately 30 % of the variation in intestinal Fe ab-
sorption [46, 54, 55]. High Fe status leads to increased
hepcidin expression, which inhibits intestinal Fe absorp-
tion and suppresses the release of Fe from body stores [9].
On the other hand, ID or increased erythropoiesis reduces
hepcidin expression to allow for enhanced Fe mobilization
and utilization [9, 56]. Testing for potential differences in
biochemical indicators of Fe status between the two geno-
types, only one marker, sTfR, was significantly impacted.
The previously reported association between rs9366637
and serum (or plasma) ferritin was not significant in our
data set, although consistent with previous observations,
SF was elevated for both homozygous and heterozygous
carriers of the derived allele, T (Additional file 1: Table S2)
[42, 43]. The lack of statistical significance was probably
due to our small sample size and the small effect of the
SNP on ferritin as reported. In our data set, sTfR was sig-
nificantly elevated in female homozygous carriers of the
Asian-common haplotype. The sTfR is a truncated version
of the membrane-bound transferrin receptor (TfR1) and
its concentration is directly proportional to the amount of
TfR1 on cell membranes, especially those of erythroid pre-
cursors [56]. TfR1 binds not only to Fe-loaded transferrin
but also to HFE on the membrane of hepatocyte. Since
TfR1 has a higher affinity for transferrin, when Fe-loaded
transferrin is abundant, HFE is released from TfR1 and
binds to transferrin receptor 2 (TfR2). The interaction be-
tween HFE and TfR2 is required to up-regulate hepcidin
and subsequently down-regulate Fe absorption [29]. In-
creased TfR1 on the cell membrane, as suggested by ele-
vated sTfR, may prevent HFE from interacting with TfR2
thereby enhancing Fe absorption. Elevated sTfR has been
associated with increased Fe absorption in some [56–59],
but not all studies [35, 46, 60]. Significant associations be-
tween sTfR and serum hepcidin have typically not been
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significant correlations between sTfR and Fe absorption or
serum hepcidin. The effect of elevated sTfR on non-heme
Fe absorption is unclear. Additionally, the observed hepci-
din concentration did not significantly differ between
the two genotypes, probably due to the large variation
and our limited sample size. Larger sample sizes will be
needed to identify the underlying mechanisms, including
the causal variants, responsible for increased Fe absorp-
tion in individuals homozygous for the Asian-common
haplotype.
Our population comparison analysis identified signifi-
cantly higher non-heme Fe absorption in Asian females
when compared to age-matched healthy Caucasian fe-
males recruited from the same city. To our knowledge,
this is the first study comparing iron absorption between
Asians and Caucasians. In spite of the concern about
batch effect, this approach of pooling data from studies
carried out at different points in time is a common prac-
tice in stable mineral isotopic studies [62, 63]. In the Fe lit-
erature this approach is often further utilized for cross-
study comparisons by adjusting iron absorption data to a
fixed concentration of storage Fe [47]. A unique property
with stable isotopes is that the natural abundance of these
isotopes is invariable over time. All measurements of Fe
absorption are referenced to natural abundance ratios and
are thus comparable across studies. Moreover, all chemi-
cals used were ultrapure and unlikely to contribute vari-
ability. However, the possibility of batch effect could not
be ruled out and larger studies with both population sam-
ples studied at the same time are needed to confirm our
observations. Our findings support other published data
on population differences in Fe status [12, 27]. Specifically,
individuals of African descent tend to have higher Fe sta-
tus when compared to whites and Hispanics of compar-
able age and sex [27]. Similarly, the United States Centers
for Disease Control and Prevention has set race-specific
guidelines that define anemia using a lower Hb concentra-
tion in African Americans [64]. Our analysis revealed that
Asian women had significantly higher Fe absorption. This
enhanced non-heme Fe absorption may be once beneficial
under conditions of limited Fe availability, but could be
now detrimental in the modern dietary environment.
Iron absorption enhancing genetic variants, coupled with
Fe-rich diets, may contribute to the increased risk of
Fe-related complex diseases, such as type 2 diabetes. In-
deed, some iron status parameters (such as hemoglobin
or serum ferritin) in Asian individuals in this study
(Additional file 1: Table S4) are significantly higher than
their Caucasian counterparts in the previous studies. Inter-
estingly, an increased iron level has been linked to a higher
disease risk for diabetes [18, 21, 22] and Asian Americans
are 30–50 % more likely to suffer from this disorder than
their Caucasian counterparts [65]. Future studies areneeded to assess the impact of population differential Fe
absorption, especially on Fe-related complex disorders.
Future studies are also needed to unravel the genetic and
molecular basis of population differential Fe absorption.
In additional to population specific or differential genetic
variants, varying expression of Fe-related genes among
populations could be responsible. We performed a prelim-
inary analysis using expression data of HapMap samples
from four populations. Interestingly, we observed signifi-
cantly higher expression of hepcidin and lower expression
of ferroportin in Chinese individuals in comparison to
Europeans (Additional file 1: Figure S4). However, since
these expression data were measured in lymphoblastoid
cell lines, it is unclear if they correlate with their levels in
more biologically relevant tissues, such as hepcidin in hep-
atocyte and ferroportin on the basolateral membrane.
Also, because there are no Fe absorption data for HapMap
individuals, we could not test if these gene expression
levels are correlated with Fe absorption. In the future,
studies measuring both Fe absorption and gene expression
in relevant tissues are required to identify genes that have
different expression levels among populations and con-
tribute to population differential Fe absorption.
Conclusions
Our study confirmed the presence of signatures of positive
selection on HFE in Asian populations and identified a
candidate adaptive haplotype. We further showed that this
candidate adaptive haplotype was associated with reduced
HFE expression. More importantly, by measuring Fe ab-
sorption in a group of women of Asian descent, we ob-
served a 22 % higher absorption in homozygous carriers of
the adaptive haplotype than non-carriers. Additionally,
compared with a group of age-matched Caucasian women,
Asian women exhibited significantly elevated Fe absorp-
tion. Overall, our study revealed possible parallel adapta-
tion of HFE gene in Europeans and Asians with different
genetic variants and suggested that regional adaptation of
HFE may have contributed to elevated Fe absorption in
Asians. Our study may help explain the population differ-
ence in Fe homeostasis and will assist the future nutritional
practice of genome-informed dietary recommendations to
avoid Fe overload and Fe-related diseases.
Methods
Evolutionary analysis
Haplotype structure analysis was conducted with haplo-
type data downloaded from Hapmap 3 [66]. SNPs within
20 Kb upstream or downstream of gene HFE and with a
minimum population frequency of 5 % were used. For
SNPs that are in perfect linkage disequilibrium (r2 = 1)
with each other, only one SNP was randomly chosen to
remove redundant information. In total, 10 SNPs were
selected (rs9295684, rs6942196, rs2794719, rs9366637,
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and rs1150658). Haplotype information was available for
170 individuals from Beijing, China and Tokyo, Japan
(Coded as CHB + JPT), 85 Chinese in Metropolitan Denver,
Colorado (CHD), 117 Utah residents with Northern and
Western European ancestry from the CEPH collection
(CEU) and 115 Yoruba in Ibadan, Nigeria (YRI). Haplo-
type network analysis was performed using the median-
joining algorithm of Network 4.6.0.0 [67]. The root was
inferred assuming that the chimpanzee allelic state at each
SNP was ancestral.
Evolutionary analysis on HFE was performed through
Haplotter [39] and HGDP Selection Browser [68]. Haplot-
ter utilized a selection detection test, iHS, to detect signals
of positive selection using HapMap data [39]. HGDP
Selection Browser presented the global distribution of SNPs
in 53 populations [68].
To further confirm observations from the HapMap and
HGDP data, we performed evolutionary analysis on HFE
using three continentally representative populations from
the 1000 Genomes Project [40], by querying the 1000
Genomes Selection Browser 1.0 [41]. The three popula-
tions used in analysis are: CHB (Han Chinese in Beijing,
China); CEU (Utah residents with Northern and Western
European ancestry); and YRI (Yoruba in Ibadan, Nigeria).
Gene expression analysis
The relationship between the rs9366637 genotype and
the HFE expression level was assessed using the geno-
type and gene expression data of Asian individuals in the
International Hapmap Project. Genotype data were re-
trieved from Hapmap 3 [66]. The expression level of HFE
was retrieved from a previous study, which used a com-
mercial whole-genome expression array (Sentrix Human-6
Expression BeadChip version 1, Illumina) to quantify the
transcriptional profiles of Epstein-Barr virus–transformed
lymphoblastoid cell lines from individuals genotyped in
the HapMap Consortium [69]. Expression signals were
transformed to the log scale before normalization. The
four technical replicates of an individual were quantile-
normalized to have the same distribution. The processed
expression value for each gene was further normalized
across all studied individuals with median normalization
so that the value is comparable across individuals [69]. In
total, we have both genotype and HFE expression data
for 43 Chinese individuals from Beijing, China and 42
Japanese individuals from Tokyo, Japan. The association
between rs9366637 and HFE expression was further tested
with data from the Genotype-Tissue Expression (GTEx)
Project, which performs genotype-expression association
analysis in a large number of human tissue or cell types
[45]. The association analysis was performed on the GTEx
Portal (http://www.gtexportal.org/) in all tissues or cells
available. The splicing effect of rs9366637 on the relativeexpression of different HFE transcripts was tested with the
sQTLseekeR method in 9 tissues (adipose, blood, blood
vessel, heart, lung, muscle, nerve, skin and thyroid) from
the GTEx Project [70].
Subjects in genotyping and absorption study
Fifty-seven women of Asian descent were recruited
through advertisement on the Cornell University campus
in Ithaca, NY from August 2012 to May 2013. Women
were eligible for the study if they met the following cri-
teria: 1) non-pregnant and 18–35 years old; 2) of Asian
descent with both maternal and paternal grandparents
from Asia; 3) not taking any vitamin or mineral supple-
ments for at least 1 month before the study and during
the 2-week dosing study interval; 4) without pre-existing
medical problems including malabsorption, blood disor-
ders, ulcers, inflammatory diseases, asthma or conditions
that might impact inflammation or Fe status; and 5) not
taking any prescribed medications known to affect Fe homeo-
stasis. Informed written consent was obtained from each
woman, and the study was approved by the Institutional
Review Board at Cornell University. A sample size of 60
participants was selected based on the frequency of the
tag SNP rs9366637 in Asian populations [66] and this
sample size was expected to yield roughly 15 women
homozygous for either allele. The sample size of about 15
in each group of homozygous individuals was selected
based on previous studies examining genetic effects on Fe
absorption [35, 36].
For the genotype and Fe status screening study, Asian
women came to the Human Metabolic Research Unit
(HMRU) at Cornell University and a venous blood sam-
ple (10 mL) was collected to determine HFE haplotype
and baseline Fe status, including hemoglobin (Hb), serum
ferritin (SF), serum transferrin receptor (sTfR), and hepci-
din. Women carrying genotypes of C/C or T/T at SNP
rs9366637, were then invited to further participate in an
iron absorption study, which required two additional visits
to the HMRU. On the first day of the absorption study,
designated as the dosing day, fasted (≥ 1.5 h) women ar-
rived at the HMRU at which time a baseline weight was
obtained and a venous blood sample was collected by either
finger stick or venipuncture (< 3 mL) based on subject pref-
erence. Participants were then given an oral dose of 57Fe
tracer as ferrous sulfate (6.3 mg 57Fe; total Fe dose of 6.6
mg) flavored with raspberry syrup (Humco, Texarkana,
TX). The dose was administered by syringe, which was pre-
and post-weighted to calculate the amount of Fe tracer con-
sumed. After consumption, participants remained fasted
for an additional 1.5 h, after which they were provided a
standardized lunch of vegetable soup, pretzels and water.
Two weeks after the ingestion of the Fe tracer, desig-
nated as the post-dosing day, participants returned to
the HMRU and a 10 mL venous blood samples was
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ment and serum Fe status indicators.Laboratory analysis
DNA was extracted from the whole blood samples of
the 57 Asian participants using a commercially available
Genomic DNA Purification Kit (Promega Corporation,
Fitchburg, WI). A 439 bp long segment centering on
rs9366637 was PCR amplified (forward primer: 5′-ATGG
TACACTGGGCTTTGGT-3′; reverse primer: 5′-TAGTG
CTGAGAAAACCCGCTT-3′) and sequenced by a Sanger
sequencing platform (ABI 3730xl). The genotype at
rs9366637 (C/C, C/T, T/T) was visually identified from
chromatograms using Chromas Lite 2.1.1 software.
Hb and hematocrit were analyzed with a hematology
analyzer (Beckman Coulter, Fullerton, CA). SF was mea-
sured by a commercially available enzyme immunoassay
procedure (Ramco Laboratories Inc, Stafford, TX). The con-
centration of sTfR was measured with an enzyme-linked
immunosorbent assay (ELISA; Ramco Laboratories Inc,
Stafford, TX). Serum folate, vitamin B-12, and C-reactive
protein (CRP) were measured by Immulite 2000 immuno-
assay system (Siemens Medical Solutions Diagnostics, Los
Angeles, CA). Hepcidin was determined with a com-
mercial Enzyme Immunoassay Kit (S-1337; Bachem, San
Carlos, CA).Isotope preparation and sample analysis
Fe isotope (57Fe at 95 % enrichment) was purchased as
the metal from Trace Sciences International (Richmond
Hill, Canada). The tracer was converted into a sterile,
pyrogen-free solution of ferrous sulfate following the
methods used by Kastenmayer et al. [71]. The isotopic
composition of the tracer solution was validated with the
use of a ThermoQuest Triton TI Magnetic Sector Thermal
Ionization Mass Spectrometer (ThermoQuest Corporation,
Bremen, Germany).
Whole-blood samples (0.5 mL) were digested with 4
mL Ultrex nitric acid in a polytetrafluoroethylene beaker.
Samples were then dried on a hot plate and dissolved in
6N ultrapure hydrochloric acid (JT Baker, Phillipsburg,
NJ). Fe was extracted with the use of modified anion ex-
change chromatography as previously described [46]. Ex-
tracted samples were reconstituted in 3 % nitric acid and
loaded onto a rhenium filament (H Cross Co, Weehawken,
NY) with 4 μL of silica gel (Sigma-Aldrich Inc, St Louis,
MO) and 4 μL of phosphoric acid (0.7 N). Isotopic ratio
of 57Fe to 56Fe (57/56Fe) was measured by thermal ionization
mass spectrometry and compared to the natural abundance
of 57/56Fe (0.02317). Relative SDs of 57/56Fe in analyzed sam-
ples averaged 0.04 %.
To control for the known effect of Fe stores on Fe ab-
sorption, percent Fe absorption was normalized to eachwoman’s measured SF concentration as follows: normalized
percent absorption = raw percent absorption * SF/40 [47].Iron absorption in Caucasian women
Eighteen women of Caucasian descent, aged 18–32 y,
were recruited on the same university campus starting in
the spring of 2007 with similar enrollment criteria as our
recruitment for Asian women. Informed written con-
sent was obtained from each subject, and the study was
approved by the Institutional Review Board at Cornell
University. Fe status markers and other molecular charac-
teristics were measured with the same experimental ap-
proaches as in Asian women except that hepcidin was
measured by a competitive ELISA (Intrinsic LifeSciences,
La Jolla, CA). Non-heme Fe absorption was assayed from
a total Fe dose of 7.6 mg of FeSO4 given in 1.5 mL of
flavored syrup. The same meals were fed on the dosing
day as detailed above. Of the total Fe load adminis-
tered, 0.9 mg was provided as 58Fe. The detailed ex-
perimental procedure and subject characteristics have
been described previously [46]. Genotyping was not done
in these samples but it was estimated that 88.36 % of
this cohort (16 individuals) were C/C, 11 % (2 indi-
viduals) were C/T, and 0.36 % (0 individual) were T/T
based on the known frequency of this haplotype among
Caucasians [66].
All data included in our project are available upon
request.Iron status and absorption data analysis
All statistical analyses were performed with R 3.1.0 [72].
Variables that were not normally distributed (SF, hepcidin)
were transformed using a natural logarithm. Potential
differences in Fe status and Fe absorption as a function
of genotypes were tested with a one-tailed two-sample
Wilcoxon rank sum test, which is a non-parametric test
without making assumptions about the distribution of var-
iables [73]. Our alternative hypothesis was that homozy-
gous carriers of the Asian-common haplotype would have
higher Fe status (as determined by Hb, SF, sTfR and TBI)
and higher percent Fe absorption than non-carriers. Pos-
sible differences in physical characteristics (age, folate,
vitamin B-12, CRP, etc.) among women with different ge-
notypes, and between Asians and Caucasians were tested
using the two-tailed, two-sample Wilcoxon rank sum test.
Simple linear regression analysis was used to determine
possible relationships between Fe status (SF, sTfR, and
Hb), percent Fe absorption and serum hepcidin concen-
trations. Comparisons of Fe status and Fe absorption be-
tween Asian and Caucasian women were performed using
one-tailed two-sample Wilcoxon rank sum test with the
alternative hypothesis that Asians have higher Fe status
and normalized Fe absorption.
Ye et al. BMC Genetics  (2015) 16:61 Page 10 of 11Additional file
Additional file 1: This file includes additional Figures (S1-S4) and
Tables (S1-S4).
Abbreviations
CEU: Utah residents with Northern and Western European ancestry; CHB: Han
Chinese in Beijing, China; CHD: Chinese in Metropolitan Denver, Colorado;
CRP: C-reactive protein; Fe: Iron; GRASP: Genome-Wide Repository of
Associations Between SNPs and Phenotypes; GTEx: The Genotype-Tissue
Expression Program; Hb: Hemoglobin; HMRU: Human Metabolic Research
Unit at Cornell University; HH: Hereditary hemochromatosis; ID: Iron
deficiency; JPT: Japanese from Tokyo, Japan; MCHC: Mean corpuscular
hemoglobin concentration; MCV: Mean corpuscular volume; SF: Serum
ferritin; SNP: Single nucleotide polymorphism; sTfR: Serum transferrin
receptor; TfR1: Transferrin receptor 1; TfR2: Transferrin receptor 2; YRI: Yoruba
in Ibadan Nigeria; ΔDAF: The difference of derived allele frequency between
two populations.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KOO, GZ, XL, CC, and KY designed and conducted the study. CC and KY
performed the experiment, statistical analyses and wrote the initial draft
manuscript. All authors assisted in the interpretation of data and in the
writing of the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
We thank Tera Kent for technical laboratory support, and Kevin Klatt, Drs.
Patrick Stover, Andy Clark and Frank Hu for commenting on the manuscript.
We also want to thank the three anonymous reviewers for their constructive
feedback. This work was supported by the 2011 seed grant from Center for
Vertebrate Genomics, Cornell University.
Author details
1Division of Nutritional Sciences, Cornell University, Ithaca, NY, USA. 2Key
Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences,
Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and
Graduate University of the Chinese Academy of Sciences, Shanghai, China.
Received: 29 January 2015 Accepted: 1 June 2015
References
1. Ye K, Gu Z. Recent advances in understanding the role of nutrition in
human genome evolution. Adv Nutr. 2011;2(6):486–96.
2. Babbitt CC, Warner LR, Fedrigo O, Wall CE, Wray GA. Genomic signatures of
diet-related shifts during human origins. Proc Biol Sci. 2011;278(1708):961–9.
3. Luca F, Perry GH, Di Rienzo A. Evolutionary adaptations to dietary changes.
Annu Rev Nutr. 2010;30:291–314.
4. Tishkoff SA, Reed FA, Ranciaro A, Voight BF, Babbitt CC, Silverman JS, et al.
Convergent adaptation of human lactase persistence in Africa and Europe.
Nat Genet. 2007;39(1):31–40.
5. Perry GH, Dominy NJ, Claw KG, Lee AS, Fiegler H, Redon R, et al. Diet and
the evolution of human amylase gene copy number variation. Nat Genet.
2007;39(10):1256–60.
6. Peng Y, Shi H, Qi XB, Xiao CJ, Zhong H, Ma RL, et al. The ADH1B Arg47His
polymorphism in east Asian populations and expansion of rice
domestication in history. BMC Evol Biol. 2010;10:15-2148-10-15.
7. Vitti JJ, Grossman SR, Sabeti PC. Detecting aatural selection in genomic
data. Annu Rev Genet. 2013;47(1):97–120.
8. Grossman SR, Andersen KG, Shlyakhter I, Tabrizi S, Winnicki S, Yen A, et al.
1000 Genomes Project, Lander ES, Schaffner SF, Sabeti PC: Identifying recent
adaptations in large-scale genomic data. Cell. 2013;152(4):703–13.
9. Viatte L, Vaulont S. Hepcidin, the iron watcher. Biochimie. 2009;91(10):1223–8.
10. Munoz M, Garcia-Erce JA, Remacha AF. Disorders of iron metabolism. Part 1:
molecular basis of iron homoeostasis. J Clin Pathol. 2011;64(4):281–6.11. Hare D, Ayton S, Bush A, Lei P. A delicate balance: Iron metabolism and
diseases of the brain. Front Aging Neurosci. 2013;5:34.
12. UNSCN. 6th report on the world nutrition situation. 2010.
13. Fretham SJ, Carlson ES, Georgieff MK. The role of iron in learning and
memory. Adv Nutr. 2011;2(2):112–21.
14. Brownlie T, Utermohlen V, Hinton PS, Haas JD. Tissue iron deficiency
without anemia impairs adaptation in endurance capacity after aerobic
training in previously untrained women. Am J Clin Nutr. 2004;79(3):437–43.
15. Han O. Molecular mechanism of intestinal iron absorption. Metallomics.
2011;3(2):103–9.
16. Rouault TA, Cooperman S. Brain iron metabolism. Semin Pediatr Neurol.
2006;13(3):142–8.
17. Liu Q, Sun L, Tan Y, Wang G, Lin X, Cai L. Role of iron deficiency and
overload in the pathogenesis of diabetes and diabetic complications. Curr
Med Chem. 2009;16(1):113–29.
18. Acton RT, Barton JC, Passmore LV, Adams PC, Speechley MR, Dawkins FW,
et al. Relationships of serum ferritin, transferrin saturation, and HFE
mutations and self-reported diabetes in the Hemochromatosis and Iron
Overload Screening (HEIRS) study. Diabetes Care. 2006;29(9):2084–9.
19. Torti SV, Torti FM. Iron and cancer: more ore to be mined. Nat Rev Cancer.
2013;13(5):342–55.
20. Munoz M, Garcia-Erce JA, Remacha AF. Disorders of iron metabolism. Part II:
iron deficiency and iron overload. J Clin Pathol. 2011;64(4):287–96.
21. Sun L, Zong G, Pan A, Ye X, Li H, Yu Z, et al. Elevated plasma ferritin is
associated with increased incidence of type 2 diabetes in middle-aged and
elderly Chinese adults. J Nutr. 2013;143(9):1459–65.
22. Sun L, Franco OH, Hu FB, Cai L, Yu Z, Li H, et al. Ferritin concentrations,
metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese.
J Clin Endocrinol Metab. 2008;93(12):4690–6.
23. Zimmermann MB, Chaouki N, Hurrell RF. Iron deficiency due to
consumption of a habitual diet low in bioavailable iron: a longitudinal
cohort study in Moroccan children. Am J Clin Nutr. 2005;81(1):115–21.
24. Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet.
2007;370(9586):511–20.
25. Mason J, Mannar V, Mock N. Controlling Micronutrient Deficiencies in Asia.
Asian Development Review. 1999;17:66–95.
26. Ma G, Jin Y, Li Y, Zhai F, Kok FJ, Jacobsen E, et al. Iron and zinc deficiencies
in China: what is a feasible and cost-effective strategy? Public Health Nutr.
2008;11(6):632–8.
27. Zacharski LR, Ornstein DL, Woloshin S, Schwartz LM. Association of age, sex,
and race with body iron stores in adults: analysis of NHANES III data. Am
Heart J. 2000;140(1):98–104.
28. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A
novel MHC class I-like gene is mutated in patients with hereditary
haemochromatosis. Nat Genet. 1996;13(4):399–408.
29. Gao J, Chen J, Kramer M, Tsukamoto H, Zhang AS, Enns CA. Interaction of
the hereditary hemochromatosis protein HFE with transferrin receptor 2 is
required for transferrin-induced hepcidin expression. Cell Metab.
2009;9(3):217–27.
30. Lucotte G, Dieterlen F. A European allele map of the C282Y mutation of
hemochromatosis: Celtic versus Viking origin of the mutation? Blood Cells
Mol Dis. 2003;31(2):262–7.
31. Distante S, Robson KJ, Graham-Campbell J, Arnaiz-Villena A, Brissot P,
Worwood M. The origin and spread of the HFE-C282Y haemochromatosis
mutation. Hum Genet. 2004;115(4):269–79.
32. Toomajian C, Ajioka RS, Jorde LB, Kushner JP, Kreitman M. A method for
detecting recent selection in the human genome from allele age estimates.
Genetics. 2003;165(1):287–97.
33. Weinberg ED. Survival advantage of the hemochromatosis C282Y mutation.
Perspect Biol Med. 2008;51(1):98–102.
34. Moalem S, Percy ME, Kruck TP, Gelbart RR. Epidemic pathogenic selection:
an explanation for hereditary hemochromatosis? Med Hypotheses.
2002;59(3):325–9.
35. Roe MA, Heath AL, Oyston SL, Macrow C, Hoogewerff JA, Foxall R, et al.
Iron absorption in male C282Y heterozygotes. Am J Clin Nutr.
2005;81(4):814–21.
36. Hunt JR, Zeng H. Iron absorption by heterozygous carriers of the HFE
C282Y mutation associated with hemochromatosis. Am J Clin Nutr.
2004;80(4):924–31.
37. Toomajian C, Kreitman M. Sequence variation and haplotype structure at
the human HFE locus. Genetics. 2002;161(4):1609–23.
Ye et al. BMC Genetics  (2015) 16:61 Page 11 of 1138. Williamson SH, Hubisz MJ, Clark AG, Payseur BA, Bustamante CD, Nielsen R.
Localizing recent adaptive evolution in the human genome. PLoS Genet.
2007;3(6):e90.
39. Voight BF, Kudaravalli S, Wen X, Pritchard JK. A map of recent positive
selection in the human genome. PLoS Biol. 2006;4(3):e72.
40. 1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD,
DePristo MA, Durbin RM, et al. An integrated map of genetic variation from
1,092 human genomes. Nature. 2012;491(7422):56–65.
41. Pybus M, Dall’Olio GM, Luisi P, Uzkudun M, Carreno-Torres A, Pavlidis P,
et al. 1000 Genomes Selection Browser 1.0: a genome browser dedicated to
signatures of natural selection in modern humans. Nucleic Acids Res.
2014;42(Database issue):D903–9.
42. Graff RE, Cho E, Lindstrom S, Kraft P, Willett WC, Eliassen AH. Premenopausal
plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the
nurses’ health study II. Cancer Epidemiol Biomarkers Prev. 2014;23(3):516–24.
43. Fairweather-Tait SJ, Guile GR, Valdes AM, Wawer AA, Hurst R, Skinner J, et al.
The contribution of diet and genotype to iron status in women: a classical
twin study. PLoS One. 2013;8(12):e83047.
44. Dorak MT, Mackay RK, Relton CL, Worwood M, Parker L, Hall AG. Hereditary
hemochromatosis gene (HFE) variants are associated with birth weight and
childhood leukemia risk. Pediatr Blood Cancer. 2009;53(7):1242–8.
45. GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat
Genet. 2013;45(6):580–5.
46. Young MF, Glahn RP, Ariza-Nieto M, Inglis J, Olbina G, Westerman M, et al.
Serum hepcidin is significantly associated with iron absorption from food
and supplemental sources in healthy young women. Am J Clin Nutr.
2009;89(2):533–8.
47. IAEA. IAEA Human Health Series No.21–Assessment of Iron Bioavailability in
Humans Using Stable Iron Isotope Techniques: International Atomic Energy
Agency. 2012. ISBN:978-92-0-126510-4. http://www-pub.iaea.org/books/
IAEABooks/8830/Assessment-of-Iron-Bioavailability-in-Humans-Using-Stable-
Iron-Isotope-Techniques.
48. Leslie R, O’Donnell CJ, Johnson AD. GRASP: analysis of genotype-phenotype
results from 1390 genome-wide association studies and corresponding
open access database. Bioinformatics. 2014;30(12):i185–94.
49. Ganesh SK, Zakai NA, van Rooij FJ, Soranzo N, Smith AV, Nalls MA, et al.
Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium.
Nat Genet. 2009;41(11):1191–8.
50. van der Harst P, Zhang W, Mateo Leach I, Rendon A, Verweij N, Sehmi J,
et al. Seventy-five genetic loci influencing the human red blood cell. Nature.
2012;492(7429):369–75.
51. Vujic Spasic M, Kiss J, Herrmann T, Galy B, Martinache S, Stolte J, et al. HFE
acts in hepatocytes to prevent hemochromatosis. Cell Metab. 2008;7(2):173–8.
52. O’Brien KO, Zavaleta N, Caulfield LE, Yang DX, Abrams SA. Influence of
prenatal iron and zinc supplements on supplemental iron absorption, red
blood cell iron incorporation, and iron status in pregnant Peruvian women.
Am J Clin Nutr. 1999;69(3):509–15.
53. Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K,
Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum,
Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academies
Press; .2001. http://www.nap.edu/openbook.php?record_id=10026.
54. Roe MA, Collings R, Dainty JR, Swinkels DW, Fairweather-Tait SJ. Plasma
hepcidin concentrations significantly predict interindividual variation in iron
absorption in healthy men. Am J Clin Nutr. 2009;89(4):1088–91.
55. Collings R, Harvey LJ, Hooper L, Hurst R, Brown TJ, Ansett J, et al. The
absorption of iron from whole diets: a systematic review. Am J Clin Nutr.
2013;98(1):65–81.
56. Li H, Ginzburg YZ. Crosstalk between iron metabolism and erythropoiesis.
Adv Hematol. 2010;2010:605435.
57. Hunt JR. High-, but not low-bioavailability diets enable substantial control of
women’s iron absorption in relation to body iron stores, with minimal
adaptation within several weeks. Am J Clin Nutr. 2003;78(6):1168–77.
58. Skikne BS. Serum transferrin receptor. Am J Hematol. 2008;83(11):872–5.
59. Tussing-Humphreys L, Pusatcioglu C, Nemeth E, Braunschweig C. Rethinking
iron regulation and assessment in iron deficiency, anemia of chronic
disease, and obesity: introducing hepcidin. J Acad Nutr Diet.
2012;112(3):391–400.
60. Young MF, Griffin I, Pressman E, McIntyre AW, Cooper E, McNanley T, et al.
Utilization of iron from an animal-based iron source is greater than that of
ferrous sulfate in pregnant and nonpregnant women. J Nutr.
2010;140(12):2162–6.61. Dallalio G, Fleury T, Means RT. Serum hepcidin in clinical specimens. Br J
Haematol. 2003;122(6):996–1000.
62. Zimmermann MB, Zeder C, Muthayya S, Winichagoon P, Chaouki N,
Aeberli I, et al. Adiposity in women and children from transition
countries predicts decreased iron absorption, iron deficiency and a
reduced response to iron fortification. Int J Obes (Lond).
2008;32(7):1098–104.
63. Abrams SA, Hicks PD, Hawthorne KM. Higher serum 25-hydroxyvitamin D
levels in school-age children are inconsistently associated with increased
calcium absorption. J Clin Endocrinol Metab. 2009;94(7):2421–7.
64. Institute of Medicine. Iron deficiency anemia: recommended guidelines for
the prevention, detection, and management among U.S. children and
women of childbearing age. Washington: National Academies Press; 1993.
65. Lee JW, Brancati FL, Yeh HC. Trends in the prevalence of type 2 diabetes in
Asians versus whites: results from the United States National Health
Interview Survey, 1997-2008. Diabetes Care. 2011;34(2):353–7.
66. International HapMap 3 Consortium, Altshuler DM, Gibbs RA, Peltonen L,
Altshuler DM, Gibbs RA, et al. Integrating common and rare genetic
variation in diverse human populations. Nature. 2010;467(7311):52–8.
67. Bandelt HJ, Forster P, Rohl A. Median-joining networks for inferring intraspecific
phylogenies. Mol Biol Evol. 1999;16(1):37–48.
68. Pickrell JK, Coop G, Novembre J, Kudaravalli S, Li JZ, Absher D, et al. Signals
of recent positive selection in a worldwide sample of human populations.
Genome Res. 2009;19(5):826–37.
69. Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP, Beazley C, et al.
Population genomics of human gene expression. Nat Genet.
2007;39(10):1217–24.
70. Monlong J, Calvo M, Ferreira PG, Guigo R. Identification of genetic variants
associated with alternative splicing using sQTLseekeR. Nat Commun.
2014;5:4698.
71. Kastenmayer P, Davidsson L, Galan P, Cherouvrier F, Hercberg S, Hurrell RF.
A double stable isotope technique for measuring iron absorption in infants.
Br J Nutr. 1994;71(3):411–24.
72. R Core Team. R: A language and environment for statistical computing. Vienna:
R Foundation for Statistical Computing; 2014. URL: http://www.R-project.org.
73. Bauer DF. Constructing confidence sets using rank statistics. J Am Stat
Assoc. 1972;67(339):687–90.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
